Synthesis of 2- and 7-substituted C19 Steroids Having a 1,4,6-triene or 1,4-diene Structure and Their Cytotoxic Effects on T47D and MDA-MB231 Breast Cancer Cells

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2010 Jul 27

PMID 20657450

Citations 1

Authors

Minwoo Kim

Eunsook Ma

Affiliations

Soon will be listed here.

Abstract

2-Chloro-, 2-bromo- and 2-azido-1,4,6-androstatriene-3,17-diones were synthesized from 1alpha,2alpha-epoxy-4,6-androstadiene-3,17-dione (2) using HCl, HBr and NaN(3), respectively. Compound 2 was also reacted with NaCN to give 2-cyano-1,4,6-androstatriene-3,17-dione (5) and 2beta-cyano-1alpha-hydroxy-4,6-androstadiene-3,17-dione (6). 6Alpha,7alpha-epoxy-1,4-androstadiene-3,17-dione (8) was reacted with HCl, HBr and NaN(3) to form the corresponding 7beta-chloro-, 7beta-bromo- and 7beta-azido-6alpha-hydroxy-1,4-androstadiene-3,17-diones. The cytotoxic activity of these compounds towards T47D (estrogen-dependent) and MDA-MB231 (estrogen-independent) breast cancer cell lines was evaluated. The 6alpha-hydroxy-7beta-substituted analogs were more active than the 2-substituted analogs on both cell lines. Compound 2 showed the highest selective activity against the T47D (IC(50) 7.1 microM) cell line and 5 showed good cytotoxic activity on MDA-MB231 (IC(50) 18.5 microM) cell line, respectively. The 6alpha,7alpha-epoxy analog 8 also showed high cytotoxic activity on both cell lines (IC(50) 17.3 microM on T47D and IC(50) 26.9 microM on MDA-MB231).

Citing Articles

High-Throughput Cancer Cell Sphere Formation for Characterizing the Efficacy of Photo Dynamic Therapy in 3D Cell Cultures.

Chen Y, Lou X, Zhang Z, Ingram P, Yoon E Sci Rep. 2015; 5:12175.

PMID: 26153550 PMC: 4495468. DOI: 10.1038/srep12175.

References

Krstic N, Bjelakovic M, Zizak Z, Pavlovic M, Juranic Z, Pavlovic V . Synthesis of some steroidal oximes, lactams, thiolactams and their antitumor activities. Steroids. 2007; 72(5):406-14. DOI: 10.1016/j.steroids.2007.02.005. View

Schulz S, Klann R, Schonfeld S, Nyce J . Mechanisms of cell growth inhibition and cell cycle arrest in human colonic adenocarcinoma cells by dehydroepiandrosterone: role of isoprenoid biosynthesis. Cancer Res. 1992; 52(5):1372-6. View

Ma E, Kim E . Epoxidation and reduction of DHEA, 1,4,6-androstatrien-3-one and 4,6-androstadien-3beta,17beta-diol. Molecules. 2007; 10(3):572-82. PMC: 6147617. DOI: 10.3390/10030572. View

Kellis Jr J, Vickery L . Purification and characterization of human placental aromatase cytochrome P-450. J Biol Chem. 1987; 262(9):4413-20. View

Brueggemeier R, Hackett J, Diaz-Cruz E . Aromatase inhibitors in the treatment of breast cancer. Endocr Rev. 2005; 26(3):331-45. DOI: 10.1210/er.2004-0015. View

OReilly J, Li N, Duax W, Brueggemeier R . Synthesis, structure elucidation, and biochemical evaluation of 7 alpha- and 7 beta-arylaliphatic-substituted androst-4-ene-3,17-diones as inhibitors of aromatase. J Med Chem. 1995; 38(15):2842-50. DOI: 10.1021/jm00015a006. View

Marsh S, Liu G . Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy. Adv Drug Deliv Rev. 2008; 61(5):381-7. DOI: 10.1016/j.addr.2008.10.003. View

Nyce J, MAGEE P, Hard G, Schwartz A . Inhibition of 1,2-dimethylhydrazine-induced colon tumorigenesis in Balb/c mice by dehydroepiandrosterone. Carcinogenesis. 1984; 5(1):57-62. DOI: 10.1093/carcin/5.1.57. View

Sadekova S, Tan L, Chow T . Identification of the aromatase in the breast carcinoma cell lines T47D and MCF-7. Anticancer Res. 1994; 14(2A):507-11. View

10.

Sharma S, Zheng W, Joshua A, Abrams D, McEwan A . Synthesis and evaluation of novel 4-amino-4,6-androstadiene-3,17-dione: an analog of formestane. Bioorg Med Chem Lett. 2008; 18(20):5563-6. DOI: 10.1016/j.bmcl.2008.09.018. View

11.

Djurendic E, Daljev J, Sakac M, Canadi J, Santa S, Andric S . Synthesis of some epoxy and/or N-oxy 17-picolyl and 17-picolinylidene-androst-5-ene derivatives and evaluation of their biological activity. Steroids. 2007; 73(1):129-38. DOI: 10.1016/j.steroids.2007.09.005. View

12.

Schwartz A, Tannen R . Inhibition of 7,12-dimethylbenz[a]anthracene- and urethan-induced lung tumor formation in A/J mice by long-term treatment with dehydroepiandrosterone. Carcinogenesis. 1981; 2(12):1335-7. DOI: 10.1093/carcin/2.12.1335. View

13.

Boros L, Puigjaner J, Cascante M, Lee W, Brandes J, Bassilian S . Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. Cancer Res. 1997; 57(19):4242-8. View

14.

Liu X, Hedge M . Aromatase inhibitors: effect of ring A and ring B unsaturation on aromatase inhibition by 4-thiosubstituted derivatives of 4-androstene-3,17-dione. Steroids. 1995; 60(5):423-7. DOI: 10.1016/0039-128x(95)00020-q. View

15.

Poza J, Rega M, Paz V, Alonso B, Rodriguez J, Salvador N . Synthesis and evaluation of new 6-hydroximinosteroid analogs as cytotoxic agents. Bioorg Med Chem. 2007; 15(14):4722-40. DOI: 10.1016/j.bmc.2007.05.003. View

16.

Jindal D, Chattopadhaya R, Guleria S, Gupta R . Synthesis and antineoplastic activity of 2-alkylaminoethyl derivatives of various steroidal oximes. Eur J Med Chem. 2003; 38(11-12):1025-34. DOI: 10.1016/j.ejmech.2003.09.002. View

17.

Bansal R, Guleria S . Synthesis of 16E-[3-methoxy-4-(2-aminoethoxy)benzylidene]androstene derivatives as potent cytotoxic agents. Steroids. 2008; 73(14):1391-9. DOI: 10.1016/j.steroids.2008.07.004. View

18.

Numazawa M, Yamaguchi S . Synthesis and structure-activity relationships of 6-phenylaliphatic-substituted C19 steroids having a 1,4-diene, 4,6-diene, or 1,4,6-triene structure as aromatase inhibitors. Steroids. 1999; 64(3):187-96. DOI: 10.1016/s0039-128x(98)00088-9. View

19.

Gervais M, Tan L . 6-Hydroximinoandrostenedione, a new specific inhibitor of estrogen biosynthesis and its effect on T47D human breast cancer cells. Anticancer Res. 1993; 13(2):383-8. View

20.

Sikora M, Cordero K, Larios J, Johnson M, Lippman M, Rae J . The androgen metabolite 5alpha-androstane-3beta,17beta-diol (3betaAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance. Breast Cancer Res Treat. 2008; 115(2):289-96. PMC: 2728015. DOI: 10.1007/s10549-008-0080-8. View